QUÉBEC — The U.S. Food and Drug Administration and the USDA have granted GRAS (generally recognized as safe) status to Inneo, a food processing aid made to eliminate Listeria monocytogenes.
This technology, developed by Canadian biotechnology company Innodal, uses antimicrobial peptides to eliminate the harmful pathogen. With this approval, Innodal is set to launch industrial-scale projects with U.S. processing companies, marking its entry into the U.S. market, the company announced.
Inneo is Innodal's flagship product and has been successfully commercialized in Canada for four years and will now be available to the U.S. market. . .
Register or Login to keep reading
Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.
If you already have an account please Log In.
